ECPG Earnings

ECPG reported its earnings on 2026-05-06, showcasing a revenue of 475.41M against an estimate of 451.70M, resulting in a 5.25% surprise. The EPS was 3.86, surpassing the expected 3.26 by 18.4%. The stock experienced a -2.4% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ECPG's earnings announcement on 2026-05-06, the stock price moved by -2.4% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, ECPG's stock price tends to shift by an average of 3.09% in the 10 days leading up to earnings and 3.63% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate ECPG's annual revenue to reach 439.72M, while the EPS is projected at 2.33. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ECPG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ECPG's stock price typically moves by 3.09% in the 10 days before its earnings and 3.63% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 2.33 and revenue of 439.72M.

The company's financial performance shows strong revenue growth, improved margins, and increased ROIC. Despite higher operating expenses, the leverage is favorable. The Q&A reveals stable market conditions and strategic share buybacks due to strong cash generation. Management's cautious AI integration is sensible given regulatory constraints. The lack of specific buyback guidance is a minor concern, but overall, the financial health and strategic initiatives suggest a positive outlook.